Childhood non-Hodgkin lymphomas in the United Kingdom: Findings from the UK Children's Cancer Study Group

Journal of Clinical Pathology

Volumn 50, Issue 2, 1997, Pages 128-134

  Wright, Dennis ^a   McKeever, Patricia ^b   Carter, Richard ^c  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Anaplastic large cell lymphoma; Burkitt lymphoma; Childhood non Hodgkin lymphoma; Lymphoblastic lymphoma

Indexed keywords

ADOLESCENT; ARTICLE; CANCER CLASSIFICATION; CHILD; CHILDHOOD CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0031049274     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.2.128     Document Type: Article

References (36)

1. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238-48.
2. Norton AJ, Isaacson PG. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed, wax embedded tissue. Am J Pathol 1987;128:225-40.
3. Mason DY, Cordell JL, Tse AJD, van Dongen JJM, van Noesel CJM, Micklem K, et al. The IgM associated protein mb-I as a marker of normal and neoplastic B-cells. J Immunol 1991;147:2474-82.
4. Orazi A, Cotton J, Cattoretti G, Kotylo PK, John K, Manning JT, Neiman RS. Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. Am J Clin Pathol 1994;102:640-5.
5. Gerard-Marchant R, Hamblin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM. Classification of non-Hodgkin's lymphomas. Lancet 1974;ii:406.
6. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelényi G, et al. Updated Kiel classification for lymphomas. Lancet 1988;i:292-3.
7. Bennett JM, Catovsky D, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976;33:451-8.
8. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
9. Berard C, O'Conor GT, Thomas LB, Torloni H. Histopathological definition of Burkitt's tumour. Bull World Health Organ 1969;40:601-7.
10. Knowell PC, Croce CM. Chromosome translocations and oncogenes in human lymphoid tumors. Am J Clin Pathol 1990;94:229-37.
11. Gutierrez M, Bahitia K, Barraga R, Diez B, Sackmann MF, de Andreas M, Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint locations and EBV association from tumors in other world regions. Blood 1992;79:3261-6.
12. Pilicci P, Knowles D, Magrath I, Dalla-Favera R. Chromosomal breakpoints and structural alterations of the C-MYC locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986;83:2984-90.
13. Neri A, Barriga F, Knowles D, Magrath I, Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1988;85:2748-54.
14. Magrath IT. The pathogenesis of Burkitt's lymphoma. In: Van de Woued GF, Klein G, eds. Advances in cancer research, San Diego: Academic Press, 1990:133-270.
15. Burkitt DP. General features and facial tumours. In: Burkitt DP, Wright DH, eds. Burkitt's lymphoma. Edinburgh and London: E and S Livingstone, 1970:6-15.
16. Wright DH. Gross distribution and haematology. In: Burkitt DP, Wright DH, eds. Burkitt's lymphoma. Edinburgh and London: E and S Livingstone, 1970:64-81.
17. Magrath IT, Sariban E. Clinical features of Burkitt's lymphoma in the USA. In: Lenoir G, O'Conor G, Olweny CLM, eds. Burkitt's lymphoma: A human cancer model. Lyon: IARC Scientific Publications, Number 60, 1985:119-27.
18. Hutchison RE, Murphy SB, Fairclough DL, Shuster JJ, Sullivan MP, Link MP, et al. Diffuse, small, non-cleaved cell lymphoma in children. Burkitt's versus non-Burkitt's types: Results from the Pédiatrie Oncology Group and St Jude Children's Research Hospital. Cancer 1989;64:23-8.
19. Payne CM, Grogan TM, Cromey DW, Bjore CG, Kerrigan DP. An ultrastructural, morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. Lab Invest 1987;57:200-18.
20. Yano T, van Krieken JHJM, Magrath IT, Longo DL, Jaffe ES, Raffeld M. Histogenetic correlations between subcategories of small, non-cleaved cell lymphomas. Blood 1992;79:1282-90.
21. Bernard A, Murphy SB, Melvin S, Bowman P, Caillaud J, Lemerle J, et al. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 1982;59:549-54.
22. Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838-41.
23. Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983;43:4486-90.
24. Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting RE, Caveriviere P, et al. Co-expression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 1988;130: 59-70.
25. Fujimoto J, Hata J, Ishii E, Kiyokawa N, Tanaka S, Morikawa Y, et al. Ki-1 lymphoma in childhood: Immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Arch [A] 1988;412:307-14.
26. Frierson HH, Belafiore FJ, Gaffey MJ, McCary WS, Innes DJ, Williams ME. Cytokeratin in anaplastic large cell lymphoma. Mod Pathol 1994;7:317-21.
27. Gustmann C, Altmannsberger M, Osborn M, Griesser H, Feller AC. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol 1991;138:1413-22.
28. Falini B, Pileri S, Stein H, Dieneman D, Dallenbach F, Delsol G, et al. Variable expression of leucocyte common (CD45) antigen in CD30 (Ki-1) positive anaplastic large cell lymphoma: Implications for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum Pathol 1990;21:624-9.
29. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, et al. Lymphohistocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990;16:383-91.
30. Pileri S, Sabattini E, Poggi IS, Amini M, Falini B, Stein H. Lymphohistiocytic T-cell lymphoma [letter]. Histopathology 1994;25:191-3.
31. Rimokh R, Magaud J-P, Berger F, Samarut J, Coiffier B, Germain O, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 1989;71:31-6.
32. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, et al. The t(2;5)(p23;q35): Recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia 1989;3:866-70.
33. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features in the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990;14:305-16.
34. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret J-L, Kristoffersson U, et al. CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990;74:161-8.
35. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene (ALK), to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-6.
36. NPM ALK: A distinct clinico-pathologic entity. Blood 1995;86:1954-60.